Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial - PubMed
Full text linksCite Display options Display options Mild psoriasis may be burdensome; if symptoms are inadequately controlled, switching therapy may be …